STOCK TITAN

Hinge Health (HNGE) holder plans $6M sale as Insight funds trade millions

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) has a notice of proposed sale on behalf of 10% stockholder Thomas Michael Triplett under Rule 144. The filing covers the potential disposition of 66,967 common shares through Raymond James & Associates, Inc., with an indicated aggregate market value of $6,027,030.00. Hinge Health common shares outstanding are listed as 62,468,721. The contemplated transaction is described as an in-kind distribution from various Insight entities, and the notice also lists multiple recent Class A share sales by Insight Venture Partners-affiliated funds over June–August 2026, including several multi-million-dollar transactions.

Positive

  • None.

Negative

  • None.
Shares to be sold 66,967 shares of common stock Proposed Rule 144 sale for Thomas Michael Triplett
Aggregate market value of shares to be sold $6,027,030.00 Value associated with 66,967 Hinge Health common shares
Shares outstanding 62,468,721 shares Hinge Health common shares listed as outstanding
Sale on 06/29/2026 by Insight Venture Partners (Cayman) X, L.P. 600,613 shares; $49,750,937.00 Class A share sale of Hinge Health on 06/29/2026
Sale on 06/29/2026 by Insight Venture Partners X, L.P. 732,444 shares; $60,670,973.32 Class A share sale of Hinge Health on 06/29/2026
Sale on 08/10/2026 by Insight Venture Partners (Cayman) X, L.P. 253,638 shares; $23,212,290.30 Class A share sale of Hinge Health on 08/10/2026
Sale on 08/10/2026 by Insight Venture Partners X, L.P. 309,309 shares; $28,307,155.48 Class A share sale of Hinge Health on 08/10/2026
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
In-Kind Distribution financial
"In-Kind Distribution from various Insight entities"
A distribution of value to shareholders or beneficiaries made by transferring assets instead of paying cash, such as shares, bonds, or property. Like receiving a box of goods rather than money, it changes what you hold rather than adding liquid funds; investors care because it affects a portfolio’s composition, liquidity, tax reporting, and cost basis for the received assets.
attorney-in-fact regulatory
"as attorney-in-fact for Thomas M. Triplett"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
10% Stockholder financial
"10% Stockholder"

FAQ

What does the Form 144 filed for HNGE disclose about planned share sales?

The notice covers a proposed disposition of 66,967 Hinge Health common shares for 10% stockholder Thomas Michael Triplett, to be processed through Raymond James & Associates, Inc. under Rule 144, with an indicated $6,027,030.00 aggregate market value.

How many Hinge Health (HNGE) shares are outstanding according to this filing?

The filing lists Hinge Health common shares outstanding as 62,468,721. This figure is provided in the securities information section alongside the proposed Rule 144 sale details.

What is the nature of the HNGE transaction described for August 10, 2026?

For August 10, 2026, the filing describes the transfer of 66,967 common shares of Hinge Health as an “In-Kind Distribution from various Insight entities.” Insight Venture Partners is identified in connection with this distribution.

Who is the person on whose behalf HNGE shares are to be sold?

The shares are to be sold for the account of Thomas Michael Triplett, identified in the filing as a 10% stockholder of Hinge Health, Inc.

Which broker is named in the HNGE Form 144 filing?

The broker named is Raymond James & Associates, Inc., located at 880 Carillon Parkway, St. Petersburg, Florida, which is listed in the securities information section of the filing.

What recent HNGE share sales by Insight Venture Partners are disclosed?

The filing lists multiple Class A share sales by Insight Venture Partners-affiliated funds between June 16 and August 10, 2026, each with specific share counts and dollar amounts, including transactions such as 600,613 shares for $49,750,937.00 on June 29, 2026.

Who signed the HNGE Form 144 and in what capacity?

The notice is signed by Melissa Fisher as a duly authorized representative of Raymond James & Associates, Inc., acting as attorney-in-fact for Thomas M. Triplett.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature